Hui (David) Shao | Chief Financial Officer
Yisheng Biopharma

Dr. David Shao is CFO of Yisheng Biopharma Co., Ltd.  a multinational vaccine company with business focus in China, USA and Sinbgapore.   Dr. Shao has over 15 years of experience in US biopharmaceutical and capital.  He was the former CFO of Aoxing Pharmaceutical (NYSE Listed), a Senior Healthcare Analyst and fund manager at Mehta Partners and Kamunting Street Capital in New York, a Principal Scientist at Roche Pharma, USA.  Dr. Shao received his Ph.D. at University of California, San Diego and MBA at Stern School of Business in New York University.